Enhanced activation of plasminogen by the urokinase pathway (uPA elevation) in patients with cancer of the oral mucosa paralleled by an increase of PAI-1 level in the tumor compared to the adjacent mucosa was shown by enzyme immunoassay. No statistically significant associations of the level of the studied proteins in the tumor with such prognostic factors as location, growth form, histological structure, differentiation degree, size, and dissemination of the primary tumor, involvement of the regional lymph nodes, and stage of the disease were detected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. S. Gershtein and N. E. Kushlinskii, Byull. Eksp. Biol. Med., 131, No. 1, 81–87 (2001).
E. S. Gershtein, Sh. Zh. Talaeva, M. N. Sandybaev, and N. E. Kushlinskii, Mol. Med., No. 1, 4–8 (2007).
R. Bacchiocchi, C. Rubini, E. Pierpaoli, et al., BMC Cancer, 8, 220 (2008).
E. A. Baker, D. J. Leaper, J. P. Hayter, and A. J. Dickenson, Br. J. Oral Maxillofac. Surg., 45, No. 8, 623–627 (2007).
M. J. Duffy, Curr. Pharm. Des., 10, No. 1, 39–49 (2004).
M. J. Duffy and C. Duggan, Clin. Biochem., 37, No. 7, 541–548 (2004).
N. Harbeck, Use of uPA and PAI-1 to Personalize Therapy in Patients with Breast Cancer. International Society of Oncology and Biomarkers 37th Meeting Biomarkers and New Treatment Strategies in Oncology (ISOBM 2009. Amsterdam, September 27–30, 2009), (2009), p. 114.
B. Hundsdorfer, H. F. Zeilhofer, K. P. Bock, et al., J. Craniomaxillofac. Surg., 33, No. 3, 191–196 (2005).
S. Nozaki, Y. Endo, S. Kawashiri, et al., Oral Oncol., 34, No. 1, 58–62 (1998).
S. Nozaki, Y. Endo, H. Nakahara, et al., Ibid., 41, No. 10, 971–977 (2005).
Z. Shi and M. S. Stack, Biochem. J., 407, No. 2, 153–159 (2007).
L. Speleman, J. D. Kerrebijn, M. P. Look, et al., Head Neck, 29, No. 4, 341–350 (2007).
P. Strojan, M. Budihna, L. Smid, et al., Anticancer Res., 20, No. 5C, 3975–3981 (2000).
S. F. Yang, W. E. Yang, W. H. Kuo, et al., Arch. Oral Biol., 53, No. 3, 287–294 (2008).
H. Zhou, Y. Tang, X. Liang, et al., Int. J. Cancer, 125, No. 2, 453–462 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 149, No. 3, pp. 323–326, March, 2010
Rights and permissions
About this article
Cite this article
Gershtein, E.S., Batsev, A.F., Matyakin, E.G. et al. Urokinase and Tissue Plasminogen Activators and Their PAI-1 Inhibitor in Tumors of Patients with Oral Mucosal Cancer: Relationship with the Main Clinical Morphological Factors. Bull Exp Biol Med 149, 347–350 (2010). https://doi.org/10.1007/s10517-010-0943-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-010-0943-y